Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Jul 23 · below the Ichimoku cloud · RSI 28 (oversold) · MACD above its signal
None of the 29 investors followed here reported a position in SXTC in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SXTC trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for SXTC.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -98.1 | -51.0 | -26.3 | 22.6 | -18.9 | 26.3 | -97.1 | -48.4 | 17.6 | -97.4 | −100.0% | ||
| 2025 | -19.3 | 1000.0 | -44.7 | -6.2 | -40.6 | 24.5 | -9.8 | -6.4 | 7.5 | -9.6 | 1.4 | 11.1 | +215.0% |
| 2024 | -51.1 | 1.5 | -14.7 | -36.9 | -0.9 | 3.8 | 1.8 | -43.3 | 16.1 | -23.4 | -28.4 | 27.0 | −87.2% |
| 2023 | 3.3 | -30.0 | -27.6 | -12.7 | -18.1 | 15.8 | -13.2 | -44.6 | 8.8 | -30.1 | -1.4 | 87.3 | −70.7% |
| 2022 | -66.9 | 1.4 | 28.4 | -23.6 | 881.3 | -16.7 | -16.6 | -3.8 | -45.2 | -22.1 | 16.7 | -22.6 | −16.6% |
| 2021 | 121.3 | -34.1 | -4.2 | -22.8 | -9.2 | 12.4 | -13.8 | -6.4 | -12.0 | -7.7 | -25.8 | -7.9 | −50.6% |
| 2020 | 19.6 | 8.1 | -47.2 | -21.4 | -10.0 | 33.1 | -24.7 | -24.4 | -18.3 | 15.5 | 6.0 | 9.7 | −59.9% |
| 2019 | -12.7 | 9.8 | -23.5 | -24.5 | -9.1 | -31.6 | 0.0 | -48.6 | -9.5 | -22.4 | -7.3 | −88.5% |
No analyst coverage for this instrument.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.